IGF2BP1 and lung adenocarcinoma: KrasG12V is known to be a driver mutation for lung adenocarcinomas [34], and we have shown that Igf2bp1 not only binds Kras RNA in mouse lung carcinoma (LKR-M) cells but also synergizes with mutant Kras in promoting human lung adenocarcinomas [11].